ConductScience.org, home

Paper28056859

Molecular chess? Hallmarks of anti-cancer drug resistance.

Cree IA and 1 other. BMC Cancer, 2017. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. Molecular chess? Hallmarks of anti-cancer drug resistance. Papers, record 28056859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28056859

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular chess? Hallmarks of anti-cancer drug resistance.
PubMed
Journal
BMC Cancer
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
8.3
iCite
Revised in PubMed
2022-03-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cree IAIan A
2Charlton PPeter

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Resistance, NeoplasmMajor topic
Medical OncologyMajor topic
NeoplasmsMajor topic
Humans
Precision Medicine

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123562214Molecular determinants of trastuzumab efficacy: What is their clinical relevance?Cancer Treat Rev2013https://conductscience.org/library/papers/23562214PubMed
226142874Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside.Cancer Treat Rev2015https://conductscience.org/library/papers/26142874PubMed
37014501Cell death: the significance of apoptosis.Int Rev Cytol1980https://conductscience.org/library/papers/7014501PubMed
415930355Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation.Clin Cancer Res2005https://conductscience.org/library/papers/15930355PubMed
526358176A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.Cancer Gene Ther2015https://conductscience.org/library/papers/26358176PubMed
620078251Glutathione S-transferases: an overview in cancer research.Expert Opin Drug Metab Toxicol2010https://conductscience.org/library/papers/20078251PubMed
725143300Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.Cancer Chemother Pharmacol2015https://conductscience.org/library/papers/25143300PubMed
824152759Tumor hypoxia as a driving force in genetic instability.Genome Integr2013https://conductscience.org/library/papers/24152759PubMed
919371598Anti- and pro-tumor functions of autophagy.Biochim Biophys Acta2009https://conductscience.org/library/papers/19371598PubMed
1027532023PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?J Immunother Cancer2016https://conductscience.org/library/papers/27532023PubMed
1224193010A comparison of methods for EGFR mutation testing in non-small cell lung cancer.Diagn Mol Pathol2013https://conductscience.org/library/papers/24193010PubMed
131735085Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer.Cancer1992https://conductscience.org/library/papers/1735085PubMed
1424531699The GIST of targeted therapy for malignant melanoma.Ann Surg Oncol2014https://conductscience.org/library/papers/24531699PubMed
1526830315Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.Drug Resist Updat2016https://conductscience.org/library/papers/26830315PubMed
1624489728Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.PLoS One2014https://conductscience.org/library/papers/24489728PubMed
1719495754Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences.Cancer Chemother Pharmacol2010https://conductscience.org/library/papers/19495754PubMed
1825765070Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.Science2015https://conductscience.org/library/papers/25765070PubMed
1924022196Targeting EGFR and PI3K pathways in ovarian cancer.Br J Cancer2013https://conductscience.org/library/papers/24022196PubMed
2016026610Cancer cell adaptation to chemotherapy.BMC Cancer2005https://conductscience.org/library/papers/16026610PubMed
2119712441Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC).BMC Cancer2009https://conductscience.org/library/papers/19712441PubMed

See all 89 referencesDownload CSV of references

Cited by146

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
42984801Pan-cancer multi-omics profiling of SRPK1 identifies tumour-specific associations with prognosis and predicted chemotherapy response in breast, colon and prostate cancer.Front Bioinform2026https://conductscience.org/library/papers/42984801PubMed
42277467Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics.Discov Oncol2026https://conductscience.org/library/papers/42277467PubMed
42266673A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial).Front Oncol2026https://conductscience.org/library/papers/42266673PubMed
42159875Role of the MDM2/p53 axis in regulating cisplatin response in tumor cells.Clin Transl Oncol2026https://conductscience.org/library/papers/42159875PubMed
42083452Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer.Mol Cancer Ther2026https://conductscience.org/library/papers/42083452PubMed
41977308Mechanisms Underlying Cancer Chemoresistance: A Starting Point to Identify New Anticancer Strategies.Int J Mol Sci2026https://conductscience.org/library/papers/41977308PubMed
41484230Migrastatic therapy as a potential game-changer in adaptive cancer treatment.Sci Rep2026https://conductscience.org/library/papers/41484230PubMed
41413149In vitro and in silico evaluation of flavonoids from Erythrina crista-galli with cytotoxic potential against MCF-7 breast cancer cell.Sci Rep2025https://conductscience.org/library/papers/41413149PubMed
41321380Epithelial-mesenchymal dynamics in cancer: Role of signalling pathways, stromal interactions and natural therapies.ADMET DMPK2025https://conductscience.org/library/papers/41321380PubMed
41205803Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation.J Adv Res2026https://conductscience.org/library/papers/41205803PubMed
41009436Transcriptomic and Cytogenetic Analysis of Oxaliplatin-Resistant Colorectal Adenocarcinoma HCT116 Cells to Identify Markers Associated with Platinum Resistance.Int J Mol Sci2025https://conductscience.org/library/papers/41009436PubMed
40867879Development and In Vitro Cytotoxicity Evaluation of Individual and Combined Injectable Solutions of Curcumin and Resveratrol Against Lung Cancer Cells.Antioxidants (Basel)2025https://conductscience.org/library/papers/40867879PubMed
40859967Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy.Drug Des Devel Ther2025https://conductscience.org/library/papers/40859967PubMed
40332396Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40332396PubMed
40330561Algae-Mediated Green Synthesis of Dextran-Coated Titanium Nanoparticles and Their Cytotoxic Potential Against MCF7 Breast Cancer Cells.Rep Biochem Mol Biol2024https://conductscience.org/library/papers/40330561PubMed
40282556Aberrant Splicing as a Mechanism for Resistance to Cancer Therapies.Cancers (Basel)2025https://conductscience.org/library/papers/40282556PubMed
40260304Circulating tumor cell markers for early detection and drug resistance assessment through liquid biopsy.Front Oncol2025https://conductscience.org/library/papers/40260304PubMed
40212121Permanently Charged Cationic Lipids-Evolution from Excipients to Therapeutic Lipids.Small Sci2024https://conductscience.org/library/papers/40212121PubMed
40164749Identification of drug-resistant individual cells within tumors by semi-supervised transfer learning from bulk to single-cell transcriptome.Commun Biol2025https://conductscience.org/library/papers/40164749PubMed
40149313An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma.Cancers (Basel)2025https://conductscience.org/library/papers/40149313PubMed

See all 146 cited byDownload CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCC14363PubTator's text mininghttps://conductscience.org/library/genes/4363NCBI Gene
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ARNT405PubTator's text mininghttps://conductscience.org/library/genes/405NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
C19orf48P84798PubTator's text mininghttps://conductscience.org/library/genes/84798NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
ITGAV3685PubTator's text mininghttps://conductscience.org/library/genes/3685NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MARCKS4082PubTator's text mininghttps://conductscience.org/library/genes/4082NCBI Gene
MLKL197259PubTator's text mininghttps://conductscience.org/library/genes/197259NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28056859

GET https://conductscience.org/api/papers/v1/28056859/references?page=2